Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue ...

As of data cutoff on March 7, 2023 ... with no observed negative effects on health-related quality of life (HRQoL) or ...

We've known about wind on Mars for decades, but thanks to new research from a Swiss team, we have a better idea of just how strong those winds are.

Artificial intelligence is rapidly becoming one of the most lucrative and sought-after fields. The ongoing digital ...

Artificial intelligence is one of the fastest-growing and highest-paying fields today. The continued digitization of ...

Findings further demonstrate the effectiveness of Roche's approved medicines in advancing treatment standards for people with blood disorders Data from innovative pipeline signals progress ...

The first-in-class drug for bronchiectasis shows promise beyond reduced exacerbations and improved lung function.

Combination therapy with cadonilimab, a first-in-class bispecific antibody targeting both PD-1 and CTLA-4, and chemotherapy offers encouraging antitumor activity and manageable safety as a first-line ...

The global compressor oil market is experiencing robust expansion, driven by surging demand from manufacturing, automotive, ...

“The data we will present at this year’s ASH meeting underscore ... 19-20 Multiple myeloma Cevostamab: Clinical and exploratory biomarker analysis from the phase Ib CAMMA-1 study shows investigational ...

Art therapy in China emerged during the 1990s and is still in its early stage of cultural adaptation and methodological refinement. This study explores the development and application of art therapy ...

Business Wire News Releases MiriCanvas Unveils AI-powered 'Match Your Vibe' Feature to Recommend Brand-Aligned Design ...